The role of neutrophils in myocardial ischemia-reperfusion injury.

[1]  F. Sellke,et al.  Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction. , 1998, The Journal of thoracic and cardiovascular surgery.

[2]  A. M. Lefer,et al.  Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. , 1998, Circulation.

[3]  E R McVeigh,et al.  Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. , 1998, Circulation.

[4]  J. Fortenberry,et al.  Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies. , 1998, The Annals of thoracic surgery.

[5]  A. M. Lefer,et al.  Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart. , 1998, Cardiovascular research.

[6]  R. Wallace,et al.  Heparin and nonanticoagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury: role of nitric oxide. , 1998, The Journal of thoracic and cardiovascular surgery.

[7]  J. T. Cope,et al.  Sodium nitroprusside exacerbates myocardial ischemia-reperfusion injury. , 1997, The Annals of thoracic surgery.

[8]  R. Cummings,et al.  Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[9]  M. Hori,et al.  Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activated potassium channels. , 1997, Circulation.

[10]  Hiroki Sato,et al.  Monoclonal antibody to ICAM‐1 preserves postischemic blood flow and reduces infarct size after ischemia‐reperfusion in rabbit , 1997, Journal of leukocyte biology.

[11]  R. Cummings,et al.  Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[12]  A. M. Lefer,et al.  Regulation of P-selectin expression in human endothelial cells by nitric oxide. , 1997, The American journal of physiology.

[13]  K. Hirata,et al.  Nitric oxide inhibits neutrophil adhesion to cytokine-activated cardiac myocytes. , 1997, The American journal of physiology.

[14]  G. Folkerts,et al.  Peroxynitrite: a two-faced metabolite of nitric oxide. , 1997, Life sciences.

[15]  J. Hammon,et al.  Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization. , 1997, The Journal of thoracic and cardiovascular surgery.

[16]  H. Sato,et al.  Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. , 1997, The Journal of pharmacology and experimental therapeutics.

[17]  E. Verrier,et al.  Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. , 1996, The Annals of thoracic surgery.

[18]  A. M. Lefer,et al.  S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  F E Schmidt,et al.  Leukocyte depletion of blood cardioplegia attenuates reperfusion injury. , 1996, The Annals of thoracic surgery.

[20]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[21]  H. Sato,et al.  Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. , 1996, The American journal of physiology.

[22]  A. M. Lefer,et al.  The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. , 1996, Cardiovascular research.

[23]  B. Lucchesi,et al.  Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. , 1996, Immunopharmacology.

[24]  F. Lallemand,et al.  Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. , 1996, The American journal of physiology.

[25]  A. M. Lefer,et al.  Direct measurement of nitric oxide release from vascular endothelial cells. , 1996, Journal of applied physiology.

[26]  H. Oku,et al.  [Simultaneous surgical revascularization for myocardial and peripheral vascular ischemia]. , 1996, Kyobu geka. The Japanese journal of thoracic surgery.

[27]  L. Horwitz,et al.  An oligosaccharide sialyl-Lewis(x) analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs. , 1996, Circulation.

[28]  G. Firestein,et al.  Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine. , 1996, Cardiovascular research.

[29]  M. Thiel,et al.  Effect of adenosine on the expression of β2 integrins and L‐selectin of human polymorphonuclear leukocytes in vitro , 1996, Journal of leukocyte biology.

[30]  M. Arai,et al.  An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion. , 1996, Journal of the American College of Cardiology.

[31]  W. Buurman,et al.  Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. , 1996, The American journal of physiology.

[32]  J. Gott,et al.  Depletion of Blood Cardioplegia Attenuates Reperfusion Injury , 1996 .

[33]  A. Buda,et al.  Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. , 1996, The American journal of physiology.

[34]  A. Buda,et al.  Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. , 1996, Circulation research.

[35]  H. Sato,et al.  L-Arginine inhibits neutrophil adherence and coronary artery dysfunction. , 1996, Cardiovascular research.

[36]  A. M. Lefer,et al.  Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[37]  W. DeCampli,et al.  Simultaneous manipulation of the nitric oxide and prostanoid pathways reduces myocardial reperfusion injury. , 1995, The Journal of thoracic and cardiovascular surgery.

[38]  R. Schulz,et al.  Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. , 1995, Cardiovascular research.

[39]  A. M. Lefer,et al.  Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. , 1995, The Annals of thoracic surgery.

[40]  A. Buda,et al.  Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. , 1995, The American journal of physiology.

[41]  J. Hammon,et al.  Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. , 1995, The Journal of thoracic and cardiovascular surgery.

[42]  K. Stöcker,et al.  Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists. , 1995, Journal of immunology.

[43]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[44]  T. Williams,et al.  Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. , 1995, The Journal of clinical investigation.

[45]  P. Kubes,et al.  Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. , 1995, The Journal of clinical investigation.

[46]  J. D. Chambers,et al.  C5a- and tumor necrosis factor-alpha-induced leukocytosis occurs independently of beta 2 integrins and L-selectin: differential effects on neutrophil adhesion molecule expression in vivo. , 1995, Blood.

[47]  D. Van Wylen,et al.  Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. , 1995, Cardiovascular research.

[48]  B. Lucchesi,et al.  Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. , 1995, Cardiovascular research.

[49]  D. Yellon,et al.  Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. , 1995, Circulation.

[50]  R. Cummings,et al.  P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin , 1995, The Journal of cell biology.

[51]  D. Sheridan,et al.  Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. , 1995, European heart journal.

[52]  A. M. Lefer,et al.  Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. , 1995, Circulation.

[53]  J. Zweier,et al.  Direct Measurement of Nitric Oxide Generation in the Ischemic Heart Using Electron Paramagnetic Resonance Spectroscopy (*) , 1995, The Journal of Biological Chemistry.

[54]  G. Schmid-Schönbein,et al.  Modification of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids , 1995, Journal of leukocyte biology.

[55]  A. M. Lefer,et al.  Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium , 1995, Journal of leukocyte biology.

[56]  T. Möröy,et al.  Complement Activation and Inhibition , 1995 .

[57]  M. Erion,et al.  Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. , 1995, Journal of immunology.

[58]  S. Rendig,et al.  Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. , 1995, The American journal of physiology.

[59]  J. Pernow,et al.  The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. , 1994, European heart journal.

[60]  J. Svendsen.  The microcirculation of the heart. With special reference to the role of reactive oxygen metabolites in the microvascular reperfusion injury. , 1994, Danish medical bulletin.

[61]  A. Buda,et al.  A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. , 1994, Circulation.

[62]  A. M. Lefer,et al.  Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. , 1994, Gastroenterology.

[63]  A. M. Lefer,et al.  Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury. , 1994, The Journal of pharmacology and experimental therapeutics.

[64]  B. Lucchesi,et al.  Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. , 1994, Circulation research.

[65]  P. Kubes,et al.  NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. , 1994, The American journal of physiology.

[66]  M. Entman,et al.  Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. , 1994, Cardiovascular research.

[67]  P. Ward,et al.  C5a-induced expression of P-selectin in endothelial cells. , 1994, The Journal of clinical investigation.

[68]  A. M. Lefer,et al.  Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction. Role of selectins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[69]  A. M. Lefer,et al.  Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. , 1994, The American journal of physiology.

[70]  J. Hammon,et al.  Coronary artery endothelial dysfunction after global ischemia, blood cardioplegia, and reperfusion. , 1994, The Annals of thoracic surgery.

[71]  J. Perrard,et al.  Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. , 1994, Circulation.

[72]  J. Gorcsan,et al.  A Potential Role for Nitric Oxide in Myocardial Stunning , 1994, Journal of cardiac surgery.

[73]  J. Mehta,et al.  Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion. , 1994, American heart journal.

[74]  A. M. Lefer,et al.  Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs , 1994, Journal of leukocyte biology.

[75]  D. G. L. Wylen,et al.  Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. , 1994 .

[76]  U. Ikeda,et al.  Neutrophil Adherence to Rat Cardiac Myocyte by Proinflammatory Cytokines , 1994, Journal of cardiovascular pharmacology.

[77]  C. Smith,et al.  P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. , 1994, The American journal of physiology.

[78]  J. Beckman,et al.  Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. , 1994, The Journal of pharmacology and experimental therapeutics.

[79]  J. Schofer,et al.  Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. , 1994, European heart journal.

[80]  A. M. Lefer,et al.  Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. , 1994, The Journal of clinical investigation.

[81]  P. Kubes,et al.  Molecular mechanisms involved in superoxide-induced leukocyte-endothelial cell interactions in vivo. , 1994, The American journal of physiology.

[82]  W. Baumgartner,et al.  Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. , 1994, The Annals of thoracic surgery.

[83]  D. Lefer,et al.  Therapeutic role of nitric oxide donors in the treatment of cardiovascular disease , 1994 .

[84]  B. Lucchesi,et al.  Complement activation and inhibition in myocardial ischemia and reperfusion injury. , 1994, Annual review of pharmacology and toxicology.

[85]  S. Thom,et al.  Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. , 1993, Science.

[86]  M. Weisfeldt,et al.  Soluble Complement Receptor Type 1 Inhibits the Complement Pathway and Prevents Contractile Failure in the Postischemic Heart Evidence That Complement Activation Is Required for Neutrophil‐Mediated Reperfusion Injury , 1993, Circulation.

[87]  J. Beckman.  Nitric oxide and peroxynitrite , 1993 .

[88]  T. Gardner,et al.  Inhibition of neutrophil adhesion reduces myocardial infarct size. , 1993, The Annals of thoracic surgery.

[89]  D. Lefer,et al.  Antineutrophil and Myocardial Protecting Actions of a Novel Nitric Oxide Donor After Acute Myocardial Ischemia and Reperfusion in Dogs , 1993, Circulation.

[90]  J. Zweier,et al.  Cardioprotective Actions of a Monoclonal Antibody Against CD‐18 in Myocardial Ischemia‐Reperfusion Injury , 1993, Circulation.

[91]  M. Entman,et al.  Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. , 1993, The Journal of clinical investigation.

[92]  J. Smith,et al.  Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (Cd11b/CD18) expression on FMLP-stimulated neutrophils. , 1993, American journal of respiratory cell and molecular biology.

[93]  J. Vinten-johansen,et al.  Receptor‐Mediated Cardioprotective Effects of Endogenous Adenosine Are Exerted Primarily During Reperfusion After Coronary Occlusion in the Rabbit , 1993, Circulation.

[94]  G. A. Limb,et al.  Early and Late Effects of Leukopenic Reperfusion on the Recovery of Cardiac Contractile Function Studies in the Transplanted and Isolated Blood‐Perfused Rat Heart , 1993, Circulation.

[95]  D. Phillips,et al.  PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.

[96]  A. M. Lefer,et al.  Monoclonal Antibody to L‐Selectin Attenuates Neutrophil Accumulation and Protects Ischemic Reperfused Cat Myocardium , 1993, Circulation.

[97]  D. Yellon,et al.  Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. , 1993, Biochemical and biophysical research communications.

[98]  W. Schlack,et al.  Adenosine A2-Receptor Activation at Reperfusion Reduces Infarct Size and Improves Myocardial Wall Function in Dog Heart , 1993, Journal of cardiovascular pharmacology.

[99]  A. M. Lefer,et al.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. , 1993, The Journal of clinical investigation.

[100]  R. Bolli.  Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993) , 1993, Cardiovascular research.

[101]  R. Engler,et al.  Severe neutrophil depletion by leucocyte filters or cytotoxic drug does not improve recovery of contractile function in stunned porcine myocardium. , 1993, Cardiovascular research.

[102]  J S Beckman,et al.  Pathological implications of nitric oxide, superoxide and peroxynitrite formation. , 1993, Biochemical Society transactions.

[103]  R. Virmani,et al.  Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence. , 1993, Journal of the American College of Cardiology.

[104]  W. Baumgartner,et al.  Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[105]  A. M. Lefer,et al.  Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. , 1993, Circulation research.

[106]  Xinliang Ma,et al.  S-Nitroso-N-acetylpenicillamine is a Potent Inhibitor of Neutrophil-Endothelial Interaction , 1993 .

[107]  W. Sluiter,et al.  Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. , 1993, Journal of cardiovascular pharmacology.

[108]  D. Lefer,et al.  Endothelial and Myocardial Cell Protection by a Cysteine‐Containing Nitric Oxide Donor After Myocardial Ischemia and Reperfusion , 1993, Journal of cardiovascular pharmacology.

[109]  A. M. Lefer,et al.  Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. , 1993, Agents and actions. Supplements.

[110]  J. Harlan,et al.  Cytokine-induced adhesion molecule expression on human umbilical vein endothelial cells is not regulated by cyclic adenosine monophosphate accumulation. , 1993, Life sciences.

[111]  D. Lefer,et al.  Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. , 1992, The American journal of physiology.

[112]  J. Svendsen,et al.  Effects of exogenous oxygen derived free radicals on myocardial capillary permeability, vascular tone, and incidence of ventricular arrhythmias in the canine heart. , 1992, Cardiovascular research.

[113]  W. Dreyer,et al.  Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. , 1992, Circulation research.

[114]  M. Entman,et al.  Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence. , 1992, The Journal of clinical investigation.

[115]  A. M. Lefer,et al.  Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. , 1992, The American journal of physiology.

[116]  A. M. Lefer,et al.  Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. , 1992, The American journal of physiology.

[117]  S. Abramson,et al.  Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. , 1992, The Journal of clinical investigation.

[118]  A. M. Lefer,et al.  Coronary Endothelial and Cardiac Protective Effects of a Monoclonal Antibody to Intercellular Adhesion Molecule‐1 in Myocardial Ischemia and Reperfusion , 1992, Circulation.

[119]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[120]  A. M. Lefer,et al.  The Role of L‐Arginine in Ameliorating Reperfusion Injury After Myocardial Ischemia in the Cat , 1992, Circulation.

[121]  R. Mentzer,et al.  Cardiac microdialysis in isolated rat hearts: interstitial purine metabolites during ischemia. , 1992, The American journal of physiology.

[122]  S. Houser,et al.  Cardiac-derived neutrophil chemotactic factors: detection in coronary sinus effluents of patients undergoing myocardial revascularization. , 1992, The Journal of thoracic and cardiovascular surgery.

[123]  S. Abramson,et al.  Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.

[124]  R. Virmani,et al.  The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury. , 1992, American heart journal.

[125]  A. M. Lefer,et al.  Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. , 1992, The Journal of pharmacology and experimental therapeutics.

[126]  H. Lutz,et al.  Coronary artery endothelial cell and smooth muscle dysfunction after global myocardial ischemia. , 1992, The Annals of thoracic surgery.

[127]  L. Horwitz,et al.  Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion. , 1991, Circulation research.

[128]  R. Engler,et al.  Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[129]  A. M. Lefer,et al.  Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. , 1991, The Journal of clinical investigation.

[130]  G. Zimmerman,et al.  Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils , 1991, The Journal of cell biology.

[131]  S. Albelda,et al.  Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.

[132]  A. M. Lefer,et al.  Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. , 1991, Circulation research.

[133]  J. Downey,et al.  Preconditioning Causes Improved Wall Motion as Well as Smaller Infarcts After Transient Coronary Occlusion in Rabbits , 1991, Circulation.

[134]  W. Dreyer,et al.  Neutrophil Accumulation in Ischemic Canine Myocardium: Insights Into Time Course, Distribution, and Mechanism of Localization During Early Reperfusion , 1991, Circulation.

[135]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[136]  A. M. Lefer,et al.  Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[137]  H. Nathan.  Nifedipine after coronary bypass grafting. , 1991, The Annals of thoracic surgery.

[138]  G. Buckberg,et al.  Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion. , 1991, The Journal of thoracic and cardiovascular surgery.

[139]  A. M. Lefer,et al.  Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion , 1991, Critical care medicine.

[140]  J. Parratt,et al.  Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances. , 1991, Cardiovascular research.

[141]  G. Angelini,et al.  ASPIRIN AND BLOOD LOSS. REPLY , 1991 .

[142]  J. Svendsen.  Myocardial capillary permeability for small hydrophilic indicators during normal physiological conditions and after ischemia and reperfusion. , 1991, Acta physiologica Scandinavica. Supplementum.

[143]  R. Virmani,et al.  Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. , 1991, Circulation.

[144]  A. M. Lefer,et al.  Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. , 1990, The American journal of physiology.

[145]  D. Das,et al.  Prevention of Myocardial Reperfusion Injury in Experimental Coronary Revascularization Following Ischemic Arrest by a Novel Antiinflammatory Drug, ONO-3144 , 1990, Journal of cardiovascular pharmacology.

[146]  W. W. Bailey,et al.  Complement activation and lung permeability during cardiopulmonary bypass. , 1990, The Annals of thoracic surgery.

[147]  A. M. Lefer,et al.  Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. , 1990, Circulation.

[148]  G. R. Carson,et al.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.

[149]  J. V. van Mourik,et al.  Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. , 1990, Journal of immunology.

[150]  B. Cronstein,et al.  The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. , 1990, The Journal of clinical investigation.

[151]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[152]  Rodger P. McEver,et al.  Rapid neutrophil adhesion to activated endothelium mediated by GMP-140 , 1990, Nature.

[153]  B. Babior.  The respiratory burst oxidase of human neutrophils , 1990 .

[154]  G. Johnson,et al.  Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. , 1990, The Journal of pharmacology and experimental therapeutics.

[155]  D. Janero,et al.  Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid. , 1989, Biochemical pharmacology.

[156]  A. Buda,et al.  Neutrophil depletion fails to modify myocardial no reflow and functional recovery after coronary reperfusion. , 1989, Journal of the American College of Cardiology.

[157]  L. Becker,et al.  Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. , 1989, Circulation.

[158]  W. Dreyer,et al.  Canine Neutrophil Activation by Cardiac Lymph Obtained During Reperfiision of Ischemic Myocardium , 1989, Circulation research.

[159]  K. Mizuno,et al.  Monoclonal Antibody , 2020, Definitions.

[160]  M. Tonnesen.  Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. , 1989, The Journal of investigative dermatology.

[161]  A. Stephenson,et al.  Regulation of human neutrophil functions by adenine nucleotides. , 1989, Journal of immunology.

[162]  B. Babior,et al.  The respiratory burst oxidase , 1994, Basic life sciences.

[163]  E. Smith,et al.  Temporal relation between neutrophil accumulation and myocardial reperfusion injury. , 1988, The American journal of physiology.

[164]  D. Blake,et al.  Inflammation: Basic Principles and Clinical Correlates , 1988 .

[165]  R. Virmani,et al.  Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. , 1987, Circulation.

[166]  G. Schmid-Schönbein.  Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. , 1987, Federation proceedings.

[167]  L. Horwitz,et al.  Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. , 1987, The Journal of clinical investigation.

[168]  D. Schrier,et al.  The effects of adenosine agonists on human neutrophil function. , 1986, Journal of immunology.

[169]  F. Rossi.  The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. , 1986, Biochimica et biophysica acta.

[170]  T. Orszulak,et al.  Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. , 1986, Circulation.

[171]  G. Buckberg,et al.  Studies of controlled reperfusion after ischemia. , 1986, The Journal of thoracic and cardiovascular surgery.

[172]  G. Weissmann,et al.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. , 1986, The Journal of clinical investigation.

[173]  G. Schmid-Schönbein,et al.  Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. , 1986, The American journal of physiology.

[174]  G. Schmid-Schönbein,et al.  Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. , 1986, The American journal of physiology.

[175]  P. Vanhoutte,et al.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. , 1986, The American journal of physiology.

[176]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[177]  G. Kammer.  ADENOSINE , 1986, The Lancet.

[178]  H. Ohto,et al.  A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. , 1985, Blood.

[179]  S. B. Kramer,et al.  Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. , 1985, Journal of immunology.

[180]  M. Entman,et al.  Selective Accumulation of the First Component of Complement and Leukocytes in Ischemic Canine Heart Muscle: A Possible Initiator of an Extra Myocardial Mechanism of Ischemic Injury , 1985, Circulation research.

[181]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.

[182]  W. J. Powell,et al.  Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2. , 1983, The Journal of clinical investigation.

[183]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[184]  L. McManus,et al.  Complement localization in ischemic baboon myocardium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[185]  G. Schmid-Schönbein,et al.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.

[186]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[187]  L. Gordon,et al.  Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. , 1979, The Journal of clinical investigation.

[188]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[189]  Role of causality in ensuring unconditional security of relativistic quantum cryptography , .

[190]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .